Cargando…
Clinical Outcomes after Upfront Surgery in Clinical Stage I–IIA Small Cell Lung Cancer
BACKGROUND: Upfront surgery followed by systemic treatment is recommended to treat clinical stage I–IIA small cell lung cancer (SCLC), but data on the clinical outcomes are sparse. Thus, this study evaluated the stage migration and long-term prognosis of surgically treated clinical stage I–IIA SCLC....
Autores principales: | Woo, Hyeok Sang, Song, Jae Won, Park, Samina, Park, In Kyu, Kang, Chang Hyun, Kim, Young Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Thoracic and Cardiovascular Surgery
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733413/ https://www.ncbi.nlm.nih.gov/pubmed/36457158 http://dx.doi.org/10.5090/jcs.22.085 |
Ejemplares similares
-
Short-term Outcomes After Upfront Chemotherapy Followed by Curative Surgery in Metastatic Colon Cancer: A Comparison With Upfront Surgery Patients
por: Han, Myung Hyun, et al.
Publicado: (2019) -
A Meta-Analysis Comparing Lobectomy versus Segmentectomy in Stage I Non-Small Cell Lung Cancer
por: Lim, Tae Yoon, et al.
Publicado: (2019) -
Clinical course of non-small cell lung cancer patients with dry pleural dissemination: Retrospective observational study
por: Kim, Woojung, et al.
Publicado: (2020) -
Electromagnetic navigation bronchoscopic dye marking for localization of small subsolid nodules: Retrospective observational study
por: Hyun, Kwanyong, et al.
Publicado: (2019) -
Real-life Long-term Outcomes of Upfront Surgery in Patients with Resectable Stage I-IIIA Non-small Cell Lung Cancer
por: Bitenc, Marko, et al.
Publicado: (2022)